JFCCX
Price
$35.43
Change
-$0.16 (-0.45%)
Updated
Oct 16 closing price
Net Assets
602.53M
VFIAX
Price
$612.10
Change
-$3.88 (-0.63%)
Updated
Oct 16 closing price
Net Assets
1.41T
Interact to see
Advertisement

JFCCX vs VFIAX

Header iconJFCCX vs VFIAX Comparison
Open Charts JFCCX vs VFIAXBanner chart's image
JHancock Fundamental All Cap Core C
Price$35.43
Change-$0.16 (-0.45%)
VolumeN/A
Net Assets602.53M
Vanguard 500 Index Admiral
Price$612.10
Change-$3.88 (-0.63%)
VolumeN/A
Net Assets1.41T
JFCCX vs VFIAX Comparison Chart in %
View a ticker or compare two or three
VS
JFCCX vs. VFIAX commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFCCX is a Hold and VFIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.41T vs. JFCCX (603M). VFIAX pays higher dividends than JFCCX: VFIAX (1.14) vs JFCCX (0.00). JFCCX was incepted earlier than VFIAX: JFCCX (11 years) vs VFIAX (25 years). JFCCX (1.90) is less costly to investors than VFIAX (0.04). JFCCX is a more actively managed with annual turnover of: 26.00 vs. VFIAX (2.00). JFCCX has a lower initial minimum investment than VFIAX: JFCCX (1000) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 14.25 vs. JFCCX (4.25). VFIAX return over 5 years is better than : 91.75 vs. JFCCX (63.41).
JFCCXVFIAXJFCCX / VFIAX
Total Expense Ratio1.830.044,575%
Annual Report Gross Expense Ratio1.900.044,750%
Fund Existence11 years25 years-
Gain YTD3.42913.53125%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets603M1.41T0%
Annual Yield % from dividends0.001.14-
Returns for 1 year4.2514.2530%
Returns for 3 years63.3381.6378%
Returns for 5 years63.4191.7569%
Returns for 10 years131.25228.5757%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INVE3.510.06
+1.74%
Identiv
ROIV17.110.12
+0.71%
Roivant Sciences Ltd
ARDT14.590.09
+0.62%
Ardent Health Inc
ADCT4.13-0.13
-3.05%
ADC Therapeutics SA
CERO2.37-0.23
-8.85%
CERO Therapeutics Holdings Inc